SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+7.99%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$89.3M
AUM Growth
+$89.3M
(-30%)
Cap. Flow
-$41.9M
Cap. Flow
% of AUM
-46.97%
Top 10 Holdings %
Top 10 Hldgs %
77.23%
Holding
46
New
11
Increased
4
Reduced
8
Closed
18
Top Buys
| 1 |
Merck
MRK
|
$8.34M |
| 2 |
United Therapeutics
UTHR
|
$5.98M |
| 3 |
Addus HomeCare
ADUS
|
$4.36M |
| 4 |
AbbVie
ABBV
|
$3.22M |
| 5 |
UnitedHealth
UNH
|
$3.14M |
Top Sells
| 1 |
Sanofi
SNY
|
$11.8M |
| 2 |
GSK
GSK
|
$8.99M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$8.75M |
| 4 |
AFAM
Almost Family Inc
AFAM
|
$5.67M |
| 5 |
CFN
CAREFUSION CORPORATION
CFN
|
$5.32M |
Sector Composition
| 1 | Healthcare | 90.04% |
| 2 | Financials | 2.5% |
| 3 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QTNT
1
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $19.1M | 10.87% | 1,123,641 -89,209 | -7% | -$1.52M |
|
|
PFNX
2
DELISTED
Pfenex Inc.
PFNX
| $10.4M | 5.93% | 653,393 +92,628 | +17% | +$1.48M |
|
|
3
Merck
MRK
$210B
| $8.34M | 4.74% | +145,000 | New | +$8.34M |
|
|
4
United Therapeutics
UTHR
$13.8B
| $5.98M | 3.4% | +34,700 | New | +$5.98M |
|
5
Cardinal Health
CAH
$35.5B
| $5.24M | 2.98% | 58,000 -4,100 | -7% | -$370K |
|
|
DMK
6
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $4.65M | 2.65% | 1,179,981 +11,415 | +1% | +$45K |
|
7
Johnson & Johnson
JNJ
$427B
| $4.53M | 2.58% | 45,000 +5,000 | +13% | +$503K |
|
|
8
Addus HomeCare
ADUS
$2.12B
| $4.36M | 2.48% | +189,466 | New | +$4.36M |
|
|
9
AbbVie
ABBV
$372B
| $3.22M | 1.83% | +55,000 | New | +$3.22M |
|
|
10
UnitedHealth
UNH
$281B
| $3.14M | 1.78% | +26,500 | New | +$3.14M |
|
|
PETX
11
DELISTED
Aratana Therapeutics, Inc.
PETX
| $2.86M | 1.63% | 178,550 -146,870 | -45% | -$2.35M |
|
|
GTS
12
DELISTED
Triple-S Management Corporation
GTS
| $2.24M | 1.27% | +112,400 | New | +$2.24M |
|
|
STML
13
DELISTED
Stemline Therapeutics, Inc.
STML
| $2.03M | 1.15% | +140,000 | New | +$2.03M |
|
14
Heron Therapeutics
HRTX
$207M
| $2M | 1.14% | +137,100 | New | +$2M |
|
|
FWP
15
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $1.91M | 1.09% | 67,455 -41,460 | -38% | -$1.17M |
|
|
AGRX
16
DELISTED
Agile Therapeutics, Inc
AGRX
| $1.89M | 1.08% | 203,732 -546,155 | -73% | -$5.06M |
|
|
BSTG
17
DELISTED
Biostage, Inc. Common Stock
BSTG
| $1.48M | 0.84% | 455,901 +320,639 | +237% | +$1.04M |
|
|
MRTX
18
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.37M | 0.78% | +46,677 | New | +$1.37M |
|
19
SCYNEXIS
SCYX
$34.9M
| $1.27M | 0.72% | 152,780 -19,801 | -11% | -$164K |
|
20
TG Therapeutics
TGTX
$4.65B
| $1.19M | 0.68% | 76,924 -25,776 | -25% | -$399K |
|
21
Eledon Pharmaceuticals
ELDN
$155M
| $930K | 0.53% | +82,283 | New | +$930K |
|
22
InspireMD
NSPR
$102M
| $713K | 0.41% | +2,227,562 | New | +$713K |
|
23
Merit Medical Systems
MMSI
$5.36B
| $467K | 0.27% | 24,235 -68,837 | -74% | -$1.33M |
|
24
ADMA Biologics
ADMA
$4.12B
| – | – | -245,930 | Closed | -$2.75M |
|
|
AKTX
25
Akari Therapeutics
AKTX
$24.8M
| – | – | -183,505 | Closed | -$881K |
|